Glycopyrrolate: Phase III data

The double-blind, U.S. Phase III GOLDEN-3 and GOLDEN-4 trials in patients ages >=40 with moderate to very severe COPD showed that twice-daily 25 and 50 ug SUN-101 delivered via the eFlow nebulizer sys...